204 related articles for article (PubMed ID: 14514923)
1. Alterations in p53 predict response to preoperative high dose chemotherapy in patients with gastric cancer.
Bataille F; Rümmele P; Dietmaier W; Gaag D; Klebl F; Reichle A; Wild P; Hofstädter F; Hartmann A
Mol Pathol; 2003 Oct; 56(5):286-92. PubMed ID: 14514923
[TBL] [Abstract][Full Text] [Related]
2. Chromosomal instability rather than p53 mutation is associated with response to neoadjuvant cisplatin-based chemotherapy in gastric carcinoma.
Ott K; Vogelsang H; Mueller J; Becker K; Müller M; Fink U; Siewert JR; Höfler H; Keller G
Clin Cancer Res; 2003 Jun; 9(6):2307-15. PubMed ID: 12796400
[TBL] [Abstract][Full Text] [Related]
3. Allelic imbalance at p53 and microsatellite instability are predictive markers for resistance to chemotherapy in gastric carcinoma.
Yashiro M; Inoue T; Nishioka N; Matsuoka T; Boland CR; Hirakawa K
Ann Surg Oncol; 2009 Oct; 16(10):2926-35. PubMed ID: 19597886
[TBL] [Abstract][Full Text] [Related]
4. p53 gene mutation, microsatellite instability and adjuvant chemotherapy: impact on survival of 388 patients with Dukes' C colon carcinoma.
Elsaleh H; Powell B; Soontrapornchai P; Joseph D; Goria F; Spry N; Iacopetta B
Oncology; 2000; 58(1):52-9. PubMed ID: 10644941
[TBL] [Abstract][Full Text] [Related]
5. Microsatellite instability predicts poor short-term survival in patients with advanced breast cancer after high-dose chemotherapy and autologous stem-cell transplantation.
Wild PJ; Reichle A; Andreesen R; Röckelein G; Dietmaier W; Rüschoff J; Blaszyk H; Hofstädter F; Hartmann A
Clin Cancer Res; 2004 Jan; 10(2):556-64. PubMed ID: 14760077
[TBL] [Abstract][Full Text] [Related]
6. Microsatellite instability in Ewing tumor is not associated with loss of mismatch repair protein expression.
Alldinger I; Schaefer KL; Goedde D; Ottaviano L; Dirksen U; Ranft A; Juergens H; Gabbert HE; Knoefel WT; Poremba C
J Cancer Res Clin Oncol; 2007 Oct; 133(10):749-59. PubMed ID: 17530287
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of p21 and p53 expression in gastric cancer.
Seo YH; Joo YE; Choi SK; Rew JS; Park CS; Kim SJ
Korean J Intern Med; 2003 Jun; 18(2):98-103. PubMed ID: 12872447
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of microsatellite-instability in gastric and gastroesophageal junction cancer patients undergoing neoadjuvant chemotherapy.
Haag GM; Czink E; Ahadova A; Schmidt T; Sisic L; Blank S; Heger U; Apostolidis L; Berger AK; Springfeld C; Lasitschka F; Jäger D; von Knebel Doeberitz M; Kloor M
Int J Cancer; 2019 Apr; 144(7):1697-1703. PubMed ID: 30499151
[TBL] [Abstract][Full Text] [Related]
9. p53 accumulation and mutation are prognostic indicators of poor survival in human gastric carcinoma.
Lim BH; Soong R; Grieu F; Robbins PD; House AK; Iacopetta BJ
Int J Cancer; 1996 Jun; 69(3):200-4. PubMed ID: 8682588
[TBL] [Abstract][Full Text] [Related]
10. Clinical impact of microsatellite instability in colon cancer following adjuvant FOLFOX therapy.
Kim ST; Lee J; Park SH; Park JO; Lim HY; Kang WK; Kim JY; Kim YH; Chang DK; Rhee PL; Kim DS; Yun H; Cho YB; Kim HC; Yun SH; Lee WY; Chun HK; Park YS
Cancer Chemother Pharmacol; 2010 Sep; 66(4):659-67. PubMed ID: 20033812
[TBL] [Abstract][Full Text] [Related]
11. Expression of p53 protein and DNA flow cytometry in gastric adenocarcinoma: implications in patients treated with adjuvant etoposide, adriamycin and cisplatin.
Büyükçelik A; Onur H; Akbulut H; Bülent Y; Ensari A; Utkan G; Onal BS; Içli F
Tumori; 2005; 91(4):302-8. PubMed ID: 16277093
[TBL] [Abstract][Full Text] [Related]
12. Microsatellite instability and loss of heterozygosity in gastric carcinoma in comparison to family history.
Keller G; Rudelius M; Vogelsang H; Grimm V; Wilhelm MG; Mueller J; Siewert JR; Höfler H
Am J Pathol; 1998 May; 152(5):1281-9. PubMed ID: 9588896
[TBL] [Abstract][Full Text] [Related]
13. Single Patient Classifier Assay, Microsatellite Instability, and Epstein-Barr Virus Status Predict Clinical Outcomes in Stage II/III Gastric Cancer: Results from CLASSIC Trial.
Roh CK; Choi YY; Choi S; Seo WJ; Cho M; Jang E; Son T; Kim HI; Kim H; Hyung WJ; Huh YM; Noh SH; Cheong JH
Yonsei Med J; 2019 Feb; 60(2):132-139. PubMed ID: 30666834
[TBL] [Abstract][Full Text] [Related]
14. The expression profile of p14, p53 and p21 in tumour cells is associated with disease-specific survival and the outcome of postoperative chemotherapy treatment in muscle-invasive bladder cancer.
Aljabery F; Shabo I; Gimm O; Jahnson S; Olsson H
Urol Oncol; 2018 Dec; 36(12):530.e7-530.e18. PubMed ID: 30539751
[TBL] [Abstract][Full Text] [Related]
15. P53 protein expression in gastric adenocarcinoma. Negative predictor of survival after postoperative adjuvant chemotherapy.
Díez M; Medrano MJ; Gutierrez A; López A; Mugüerza JM; Hernández P; Lozano O; Noguerales F; Ruíz A; Granell J
Anticancer Res; 2000; 20(5C):3929-33. PubMed ID: 11268479
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of expression of Kit67, p53, TopoIIa and GSTP1 for curatively resected advanced gastric cancer patients receiving adjuvant paclitaxel plus capecitabine chemotherapy.
Zha Y; Cun Y; Zhang Q; Li Y; Tan J
Hepatogastroenterology; 2012; 59(117):1327-32. PubMed ID: 22534478
[TBL] [Abstract][Full Text] [Related]
17. Microsatellite instability in sporadic gastric cancer: its prognostic role and guidance for 5-FU based chemotherapy after R0 resection.
An JY; Kim H; Cheong JH; Hyung WJ; Kim H; Noh SH
Int J Cancer; 2012 Jul; 131(2):505-11. PubMed ID: 21898388
[TBL] [Abstract][Full Text] [Related]
18. Implications of p53 alterations and anti-p53 antibody response in head and neck squamous cell carcinomas.
Lavieille JP; Righini C; Reyt E; Brambilla C; Riva C
Oral Oncol; 1998 Mar; 34(2):84-92. PubMed ID: 9682769
[TBL] [Abstract][Full Text] [Related]
19. Alterations of APC, c-met, and p53 genes in tumor tissue and serum of patients with gastric cancers.
Wang JY; Hsieh JS; Chen CC; Tzou WS; Cheng TL; Chen FM; Huang TJ; Huang YS; Huang SY; Yang T; Lin SR
J Surg Res; 2004 Aug; 120(2):242-8. PubMed ID: 15234219
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the predictive value of Her-2/neu overexpression and p53 mutations in high-risk primary breast cancer patients treated with high-dose chemotherapy and autologous stem-cell transplantation.
Nieto Y; Cagnoni PJ; Nawaz S; Shpall EJ; Yerushalmi R; Cook B; Russell P; McDermit J; Murphy J; Bearman SI; Jones RB
J Clin Oncol; 2000 May; 18(10):2070-80. PubMed ID: 10811672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
